News

Press Releases

Sep 17, 2019

CRISPR Therapeutics and ViaCyte Present Positive In Vitro Data Towards a Potential Immune-Evasive Cell Replacement Therapy for Diabetes at EASD 2019

Jul 31, 2019

CRISPR Therapeutics to Present at Upcoming Investor Conferences

Jul 29, 2019

CRISPR Therapeutics Provides Business Update and Reports Second Quarter 2019 Financial Results

Jul 01, 2019

CRISPR Therapeutics Announces Oral Presentation at the 55th Annual Meeting of the European Association for the Study of Diabetes

View All Press

Presentations

Sep 17, 2019

2019 European Association for the Study of Diabetes (EASD) Presentation

Jul 31, 2019

CRISPR Therapeutics Corporate Presentation

May 02, 2019

2018 AR LOGO

May 02, 2019

2019 Proxy Statement

View All Presentations

Events

Wednesday, June 13, 2018 8:00 a.m. PT

CRISPR Therapeutics at Goldman Sachs 39th Annual Global Healthcare Conference